Notify me when Seven Fleet Partners LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Common Stock, par value $0.0001 per share | 1.9% | $39,333,320 | 1,515,151 | Seven Fleet Partners LP | 11 Sep 2025 | ||
| CTMX | CytomX Therapeutics, Inc. | Common Stock, $0.00001 par value per share | 0.2% | $267,784 | 377,161 | Seven Fleet Partners LP | 13 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|